Articles from Valion Bio, Inc.

Valion Bio Announces U.S. Government-Funded Entolimod Studies Targeting Lethal Radiation-Induced GI Injury
AFRRI/NIAID Program to Advance Safety and Therapeutic Studies in Rapid Sequence; Top-Line Therapeutic Data Expected in Early Fall
By Valion Bio, Inc. · Via ACCESS Newswire · August 12, 2026
Articles from Valion Bio, Inc. | Hannibal Courier - Post